Here's Why Biotech Stocks Got Smashed


Did you see the Biotech sector get smashed today, with the Nasdaq Biotech ETF and the SPDR Biotech ETF , down by about 1.5 percent and 2 percent? What was that? Just look at the graph below, with Exact Sciences , down by nearly 13 percent, Exelixis down by over 7 percent, and Amicus down by more than 6 percent. Just smashed! It comes down to this, with the JPMorgan Healthcare conference ongoing, companies are pre-releasing quarterly results and outlooks for 2018, and to this point, some of the results have not been inspiring, and when you are a hyper-growth company, inline just doesn't cut it.



from Biotech News